CN105219882A - Mycobacterium avium-intracellulare compound group detects by primer and probe and its detection method - Google Patents

Mycobacterium avium-intracellulare compound group detects by primer and probe and its detection method Download PDF

Info

Publication number
CN105219882A
CN105219882A CN201510801925.0A CN201510801925A CN105219882A CN 105219882 A CN105219882 A CN 105219882A CN 201510801925 A CN201510801925 A CN 201510801925A CN 105219882 A CN105219882 A CN 105219882A
Authority
CN
China
Prior art keywords
intracellulare
primer
mycobacterium avium
seqidno
compound group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510801925.0A
Other languages
Chinese (zh)
Inventor
李光
马志远
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Leadman Biochemistry Co ltd
Original Assignee
Beijing Leadman Biochemistry Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Leadman Biochemistry Co ltd filed Critical Beijing Leadman Biochemistry Co ltd
Priority to CN201510801925.0A priority Critical patent/CN105219882A/en
Publication of CN105219882A publication Critical patent/CN105219882A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of primer for detecting mycobacterium avium-intracellulare compound group and probe and its detection method, this primer comprises upstream primer for detecting mycobacterium avium and downstream primer, does is its nucleotide sequence respectively the SEQ in sequence table ID NO.1 and SEQ ID NO.2; And for the upstream primer that detects Mycobacterium intracellulare and downstream primer, its nucleotide sequence is respectively the SEQ in sequence table ID NO.3 and SEQ ID NO.4.Does does this Taqman probe comprise and have SEQ in sequence table ID NO.5 and SEQ ID two Taqman probes of NO.6; 5 ' end of two described probes is marked with reporter fluorescence group, and 3 ' end is marked with quenching fluorescence group.The method comprises extracts sample genomic dna to be detected, and configuration quantitative fluorescent PCR reaction system, carries out the steps such as PCR reaction.Primer provided by the invention, probe, method to can be used in clinical and scientific research mycobacterium avium-intracellulare compound group and detect, and detect simultaneously, differentiate mycobacterium avium and Mycobacterium intracellulare, highly sensitive, sampling less, fast and convenient.

Description

Mycobacterium avium-intracellulare compound group detects by primer and probe and its detection method
Technical field
The present invention relates to biology field, refer to a kind of mycobacterium avium-intracellulare compound group detection primer and probe and its detection method especially.
Background technology
Non-tuberculous mycobacteria is extensively present in natural soil, dust, water, and in fish and poultry, route of transmission mainly obtains infection from environment, such as sewage, and human-to-human transmission is seldom shown in.Comparatively mycobacterium tuberculosis is low to human pathogenic for this type of mycobacterium usual, if but there is predisposing factor, make host local or general immunity function generation obstacle, then can cause pathology.Non-tuberculous mycobacteria wherein with mycobacterium avium-intracellulare compound group (M.aviumcomplex) mycobacterium kansasii (M.Kartsasii) and mycobacterium xenopi (M.xenopi) for causing the most common pathogen of pulmonary lesion.
Mycobacterium avium disease infects by bird-Mycobacterium intracellulare complex body (Mycobacteriumaviumcomplex or Mycobacteriumavium-intracellularecomplex, MAIC) the Zoonosis sexually transmitted disease caused.MAIC can encroach on Various Tissues organ after infecting and comprise lung, marrow and lymphoglandula etc.Clinical disease mainly comprises single tubercle, tubercular bronchiectasis, tuberculiform infiltration and the diffustivity in immunocompromised patients and infiltrates Four types.
At present, the method that in laboratory, identification of mycobacterium adopts is smear method and culture method.Mycobacterium tuberculosis and non-tuberculous mycobacteria can not separate by smear method; Culture method is accurately but need to cultivate and could confirm for 2-3 time, and consuming time long.Also there are some molecular biological variety identification methods for mycobacterium avium-intracellulare compound group in the last few years, but also all need 4-6 hour, as reverse hybridized, PCR-RFLP etc., and easily there is laboratory pollution.
Summary of the invention
In view of this, the object of the invention is to propose a kind of mycobacterium avium-intracellulare compound group detection primer and probe and its detection method.
Based on the above-mentioned purpose primer for detecting mycobacterium avium-intracellulare compound group provided by the invention, comprise the upstream primer for detecting mycobacterium avium and downstream primer, its nucleotide sequence is respectively SEQIDNO.1 and SEQIDNO.2 in sequence table; And for the upstream primer that detects Mycobacterium intracellulare and downstream primer, its nucleotide sequence is respectively SEQIDNO.3 and SEQIDNO.4 in sequence table.
The primer sequence derived by above-mentioned primer also belongs to protection scope of the present invention.Described derived sequence refers at SEQIDNO.1 and/or SEQIDNO.2, and through primer sequence that the replacement of one to ten base, disappearance or interpolation obtain on the basis of SEQIDNO.3 and/or SEQIDNO.4.
Based on identical inventive concept, present invention also offers the Taqman probe for detecting mycobacterium avium-intracellulare compound group, comprising two Taqman probes with SEQ ID NO.5 and SEQIDNO.6; 5 ' end of two described probes is marked with reporter fluorescence group, and 3 ' end is marked with quenching fluorescence group.
Preferably, the 5 ' end described in the probe of SEQ ID NO.5 marks JOE, 3 ' end mark BHQ; Described 5 ' the end flag F AM with the probe of SEQ ID NO.6,3 ' end mark BHQ.
Also protection scope of the present invention is belonged to by the derived sequence of above-mentioned Taqman probe sequence.Described derived sequence is on the basis of SEQIDNO.5 and/or SEQIDNO.6, in the sequence that 5 ' end and/or the one or more base of 3 ' end interpolation of sequence obtain.
Based on identical inventive concept, present invention also offers mycobacterium avium-intracellulare compound group detection kit, comprising the primer for detecting mycobacterium avium-intracellulare compound group and Taqman probe.
Based on identical inventive concept, present invention also offers a kind of method detecting mycobacterium avium-intracellulare compound group, adopt above-mentioned primer for detecting mycobacterium avium-intracellulare compound group and the above-mentioned Taqman probe for detecting mycobacterium avium-intracellulare compound group, with sample genomic dna to be detected for template, carry out quantitative fluorescent PCR, its step is as follows:
1) sample genomic dna to be detected is extracted;
2) quantitative fluorescent PCR reaction system is configured: template 5 μ l, 10 × Taq enzyme buffer5 μ l, 2.5mMdNTP4 μ l, each 2 μ l of upstream primer and downstream primer for detecting mycobacterium avium, its concentration is 10 μMs, the each 2 μ l of upstream primer and downstream primer for detecting Mycobacterium intracellulare, concentration is 10 μMs, each 1 μ l of two Taqman probes of SEQ ID NO.5 and SEQIDNO.6, concentration is 10 μMs, Taq enzyme 2.5U, UNG enzyme 0.01 μ l, ddH 2o mends to 50 μ l;
3) PCR reaction is carried out: reaction conditions is: 50 DEG C of 2min; 94 DEG C of 5min; 94 DEG C of 30s, 60 DEG C of 40s, totally 40 circulations; Quantitative real time PCR Instrument increases, collects signal.
As can be seen from above, mycobacterium avium-intracellulare compound group provided by the invention detects by primer and probe and its detection method.Utilize mycobacterium avium and the genome difference between Mycobacterium intracellulare and other mycobacteriums, design 2 pairs of primers and 2 probes, target fragment according to amplification designs Taqman probe respectively, and different fluorescent marks is carried out to two probes, achieve detect mycobacterium avium and Mycobacterium intracellulare simultaneously in same reaction tubes, and differentiated by different fluorescence channels, can direct sentence read result on software while amplification, and without leakage of electricity swimming, avoid Aerosol Pollution.The feature such as there is sensitivity and specificity is high, can realize multiple reaction, level of automation is high, pollution-free, real-time and accurate.Have compared with traditional discrimination method highly sensitive, sample less, the advantage such as fast and convenient.
Accompanying drawing explanation
Fig. 1 uses mycobacterium avium-intracellulare compound group detection primer and probe in embodiments of the invention, with mycobacterium avium genomic dna for template, carry out fluorescent quantitative PCR graphic representation;
Fig. 2 uses mycobacterium avium-intracellulare compound group detection primer and probe in the embodiment of the present invention, with Mycobacterium intracellulare genomic dna for template, carry out fluorescent quantitative PCR graphic representation;
Fig. 3 uses mycobacterium avium-intracellulare compound group detection primer and probe in the embodiment of the present invention, with mycobacterium avium and Mycobacterium intracellulare genomic dna for template, carry out fluorescent quantitative PCR graphic representation.
Embodiment
For making the object, technical solutions and advantages of the present invention clearly understand, below in conjunction with specific embodiment, and with reference to accompanying drawing, the present invention is described in more detail.
Embodiment 1: mycobacterium avium-intracellulare compound group detects the Design and synthesis with primer and probe
Various Mycobacterium tuberculosis genes group sequences according to providing in gene pool in Pub-Med are compared, find that various mycobacterium is variant in 16SrRNA sequence, mycobacterium is at the not conservative region of 16SrRNA, design primer and probe is carried out according to these difference, thus mycobacterium compound group in bird born of the same parents is therefrom distinguished, concrete sequence is as follows:
For the primer of mycobacterium avium, probe be:
Upstream primer AF:5 '-GGAAAGGCCTCTTCGGAGGT-3 ' (SEQ ID NO.1);
Downstream primer AR:5 '-CGCAAAAGCTTTCCACCAGA-3 ' (SEQ ID NO.2),
Probe AP sequence is: 5 '-CGGATAGGACCTCAAGACGCATGTC-3 ' (SEQ ID NO.5).
For the primer of Mycobacterium intracellulare, probe be:
Upstream primer: IF:5 '-CCCCTTCGGGGGTACTCG-3 ' (SEQ ID NO.3),
Downstream primer IR:5 '-CCGCAAAAGCTTTCCACCTAA-3 ' (SEQ ID NO.4),
Probe I P sequence is: 5 '-ACCGGATAGGACCTTTAGGCGCATG-3 ' (SEQ ID NO.6).
Wherein, two Taqman probes are respectively for mycobacterium avium and Mycobacterium intracellulare, and 5 ' the end mark JOE of the probe AP of mycobacterium avium, 3 ' end marks BHQ, 5 ' the end flag F AM of the probe I P of Mycobacterium intracellulare, 3 ' end mark BHQ.When only there is Mycobacterium intracellulare DNA in testing sample, the Mycobacterium intracellulare system in reaction system can increase, and has fluorescent signal to occur at FAM passage, and has real-time amplification curve; When only there is mycobacterium avium DNA in sample, in reaction system, mycobacterium avium system can increase, and has fluorescent signal to occur at JOE passage, and has real-time amplification curve; When to there is the DNA of two kinds of bacterium simultaneously, two individual system can work simultaneously (note: concentration ratio is at 1:10 3within), all can there is real-time amplification curve at two passages, thus realize the discriminating to both.Come to be mycobacterium avium and Mycobacterium intracellulare in judge templet by the fluorescence curve observed at the fluorescent signal of different passage.
The synthesis of all primers and probe and mark have all been come by the raw work in Shanghai.
Embodiment 2: apply primer provided by the invention and probe detects mycobacterium avium-intracellulare compound group
1. extract sample genomic dna to be detected:
1) get clinical sputum sample and originally carry out screening and number record smear results;
2) 8%NaOH solution is prepared;
3) in Biohazard Safety Equipment, in sputum, the above-mentioned sodium hydroxide solution of equal-volume is added;
4) the rear 37 DEG C of liquefaction of concuss mixing 1 hour;
5) sample of 1ml post liquefaction is got in 1.5ml sterile centrifugation tube;
6) 12000rpm, abandons supernatant after centrifugal 10min;
7) concussion mixing after adding stroke-physiological saline solution 1ml in this centrifuge tube;
8) 12000rpm, abandons supernatant after centrifugal 10min;
9) mix after adding sterilized water 105 μ l;
10) entire contents in pipe is transferred in new aseptic 1.5ml centrifuge tube;
11) cooling is taken out after 95 DEG C of heating in water bath 10min;
12) 12000rpm, centrifugal 2min;
13) proceed to freezing storing box ,-20 DEG C save backup for a long time.
2. configure quantitative fluorescent PCR reaction system:
Experiment material: mycobacterium avium, Mycobacterium intracellulare, Mycobacterium tuberculosis H37Rv, BCG strain, other mycobacterium, respiratory tract common bacteria, Taq enzyme suit (Takara), primer AF and AR, IF and IR, probe AP and IP, ddH 2o.
Laboratory apparatus: ABI7500 quantitative real time PCR Instrument.
Sequence number Component Initial concentration Quantity
1 Ultrapure water / Mend to 50 μ l
2 10×buffer / 5μl
3 Primer AF 10μM 2μl
4 primer AR 10μM 2μl
5 primer IF 10μM 2μl
6 primer IR 10μM 2μl
7 Probe AP 10μM 1μl
8 Probe IP 10μM 1μl
9 Taq enzyme 5U/L 0.5μl
10 dNTP 25mM 4μl
11 UNG enzyme 1U/μl 0.01μl
12 Template 5μl
Total 50μl
3. carry out PCR reaction:
Be configured according to above-mentioned system, ABI7500 quantitative real time PCR Instrument increases, the reaction conditions of PCR is as follows: 50 DEG C, 2min, 94 DEG C of 5min; 94 DEG C of 30s, 60 DEG C of 40s, totally 40 circulations; Quantitative real time PCR Instrument increases, signal collection is carried out to FAM and JOE passage.
Respectively with the nucleic acid extracted after the nucleic acid extracted after the deactivation of mycobacterium avium pure growth, the deactivation of Mycobacterium intracellulare pure growth and both mixtures for template, detect.Fig. 1-3 is respectively in the embodiment of the present invention and uses mycobacterium avium-intracellulare compound group detection primer and probe, with above-mentioned genomic dna for template, carries out fluorescent quantitative PCR graphic representation.
As Figure 1-3, time in a template only containing mycobacterium avium genomic dna, only there is amplification curve at the passage of corresponding mycobacterium avium, and do not have amplification curve to occur for the passage of Mycobacterium intracellulare; Time in a template only containing Mycobacterium intracellulare genomic dna, only there is amplification curve at the passage of corresponding Mycobacterium intracellulare, and do not have amplification curve to occur for the passage of mycobacterium avium; Time in a template simultaneously containing mycobacterium avium and Mycobacterium intracellulare genomic dna, fluorescent signal can be detected at two passages.
As can be seen from above, two kinds of systems can well carry out work in same reaction tubes, do not have cross reaction.
Embodiment 3: with the cross reactivity of other mycobacteriums and respiratory pathogen
By the detection method in embodiment 2, respectively with common branches bacillus and respiratory pathogen for sample, detect.
For other common mycobacterium (concrete title is as following table), prepares corresponding DNA profiling, detected by this system, represented to reach the cycle number increased required for threshold value.Result is as follows:
Other common branches bacillus detected result of table 1
Strain name Detected result Whether intersect
Mycobacterium abscessus ND (detected result is negative) No
Mycobacterium chelonei ND (detected result is negative) No
Mycobacterium fortuitum ND (detected result is negative) No
Golden mycobacterium ND (detected result is negative) No
Mycobacterium xenopi ND (detected result is negative) No
Mycobacterium marinum ND (detected result is negative) No
Mycobacterium phlei ND (detected result is negative) No
Mycobacterium avium-intracellulare compound group 23.21 ----
As can be seen from the results, this system can identify mycobacterium avium and Mycobacterium intracellulare (i.e. mycobacterium compound group in bird born of the same parents), does not intersect to other mycobacterium.
Respiratory tract common causative detected result is as following table:
Table 2 and common respiratory pathogen detected result
As can be seen from result, this system can identify mycobacterium avium and Mycobacterium intracellulare (i.e. mycobacterium compound group in bird born of the same parents), does not intersect to other respiratory tract common bacteria.
In sum, the present invention is according to the difference of mycobacterium avium-intracellulare compound group with other Mycobacterium tuberculosis genes group, design 2 pairs of primers, article two, Taqman probe is respectively for mycobacterium avium and Mycobacterium intracellulare, mark JOE held by the probe 5 ' of mycobacterium avium, 3 ' end mark BHQ, flag F AM held by the probe 5 ' of Mycobacterium intracellulare, 3 ' end mark BHQ.When only there is Mycobacterium intracellulare DNA in testing sample, the Mycobacterium intracellulare system in reaction system can increase, and has fluorescent signal to occur at FAM passage, and has real-time amplification curve; When only there is mycobacterium avium DNA in sample, in reaction system, mycobacterium avium system can increase, and has fluorescent signal to occur at JOE passage, and has real-time amplification curve; When to there is the DNA of two kinds of bacterium simultaneously, two individual system can work simultaneously (note: concentration ratio is at 1:10 3within), all can there is real-time amplification curve at two passages, thus realize the discriminating to both.Can direct sentence read result on software while amplification, and swim without leakage of electricity, avoid Aerosol Pollution.The feature such as there is sensitivity and specificity is high, can realize multiple reaction, level of automation is high, pollution-free, real-time and accurate.Have compared with traditional discrimination method highly sensitive, sample less, the advantage such as fast and convenient.
Those of ordinary skill in the field are to be understood that: the discussion of above any embodiment is only exemplary, and not intended to be implies that the scope of the present disclosure (comprising claim) is limited to these examples; Under thinking of the present invention, also can combine between technical characteristic in above embodiment or different embodiment, step can realize with random order, and there are other changes many of different aspect of the present invention as above, and they do not provide in details for the sake of simplicity.Therefore, within the spirit and principles in the present invention all, any omission made, amendment, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.

Claims (9)

1. for detecting the primer of mycobacterium avium-intracellulare compound group, it is characterized in that, comprise the upstream primer for detecting mycobacterium avium and downstream primer, its nucleotide sequence is respectively SEQIDNO.1 and SEQIDNO.2 in sequence table; And for the upstream primer that detects Mycobacterium intracellulare and downstream primer, its nucleotide sequence is respectively SEQIDNO.3 and SEQIDNO.4 in sequence table.
2. the derived sequence of primer described in claim 1.
3. derived sequence according to claim 2, it is characterized in that: described derived sequence is at SEQIDNO.1 and/or SEQIDNO.2, and through primer sequence that the replacement of one to ten base, disappearance or interpolation obtain on the basis of SEQIDNO.3 and/or SEQIDNO.4.
4. for detecting the Taqman probe of mycobacterium avium-intracellulare compound group, it is characterized in that, comprising two Taqman probes with SEQ ID NO.5 and SEQIDNO.6; 5 ' end of two described probes is marked with reporter fluorescence group, and 3 ' end is marked with quenching fluorescence group.
5. the Taqman probe for detecting mycobacterium avium-intracellulare compound group according to claim 4, is characterized in that, described in have the probe of SEQ ID NO.5 5 ' end mark JOE, 3 ' end mark BHQ; Described 5 ' the end flag F AM with the probe of SEQ ID NO.6,3 ' end mark BHQ.
6. the derived sequence of Taqman probe according to claim 5.
7. according to claim 6, it is characterized in that, described derived sequence is on the basis of SEQIDNO.5 and/or SEQIDNO.6, in the sequence that 5 ' end and/or the one or more base of 3 ' end interpolation of sequence obtain.
8. a mycobacterium avium-intracellulare compound group detection kit, it is characterized in that, comprising primer for detecting mycobacterium avium-intracellulare compound group according to claim 1 and the Taqman probe for detecting mycobacterium avium-intracellulare compound group according to claim 4.
9. one kind is detected the method for mycobacterium avium-intracellulare compound group, it is characterized in that, adopt primer for detecting mycobacterium avium-intracellulare compound group according to claim 1 and the Taqman probe for detecting mycobacterium avium-intracellulare compound group according to claim 4, with sample genomic dna to be detected for template, carry out quantitative fluorescent PCR, its step is as follows:
1) sample genomic dna to be detected is extracted;
2) quantitative fluorescent PCR reaction system is configured: template 5 μ l, 10 × Taq enzyme buffer5 μ l, 2.5mMdNTP4 μ l, each 2 μ l of upstream primer and downstream primer for detecting mycobacterium avium, its concentration is 10 μMs, the each 2 μ l of upstream primer and downstream primer for detecting Mycobacterium intracellulare, concentration is 10 μMs, each 1 μ l of two Taqman probes of SEQ ID NO.5 and SEQIDNO.6, concentration is 10 μMs, Taq enzyme 2.5U, UNG enzyme 0.01 μ l, ddH2O mend to 50 μ l;
3) PCR reaction is carried out: reaction conditions is: 50 DEG C of 2min; 94 DEG C of 5min; 94 DEG C of 30s, 60 DEG C of 40s, totally 40 circulations; Quantitative real time PCR Instrument increases, collects signal.
CN201510801925.0A 2015-11-19 2015-11-19 Mycobacterium avium-intracellulare compound group detects by primer and probe and its detection method Pending CN105219882A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510801925.0A CN105219882A (en) 2015-11-19 2015-11-19 Mycobacterium avium-intracellulare compound group detects by primer and probe and its detection method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510801925.0A CN105219882A (en) 2015-11-19 2015-11-19 Mycobacterium avium-intracellulare compound group detects by primer and probe and its detection method

Publications (1)

Publication Number Publication Date
CN105219882A true CN105219882A (en) 2016-01-06

Family

ID=54989148

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510801925.0A Pending CN105219882A (en) 2015-11-19 2015-11-19 Mycobacterium avium-intracellulare compound group detects by primer and probe and its detection method

Country Status (1)

Country Link
CN (1) CN105219882A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107805666A (en) * 2016-09-07 2018-03-16 江苏奇天基因生物科技有限公司 A kind of method that mycobacterium avium-intracellulare complex is detected using isothermal amplification
CN108531622A (en) * 2017-03-06 2018-09-14 广州市宝创生物技术有限公司 The hybond membrane item and detection kit of mycobacterium tuberculosis complex and the compound group of the extracellular mycobacteria of bird-
CN110938702A (en) * 2019-11-28 2020-03-31 北京市结核病胸部肿瘤研究所 Method for detecting mycobacterium avium by real-time fluorescent PCR and application thereof
CN112538539A (en) * 2020-11-26 2021-03-23 中国医学科学院北京协和医院 Kit and system for detecting mycobacterium avium
CN112538541A (en) * 2020-11-26 2021-03-23 中国医学科学院北京协和医院 Kit and system for detecting M.intracellulare

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010019822A1 (en) * 1997-06-25 2001-09-06 Kevin M. Gorman Multiplexed pcr assay for detecting disseminated mycobacterium avium complex infection
CN102286627A (en) * 2011-09-08 2011-12-21 北京利德曼生化股份有限公司 Simultaneous identification method for mycobacterium bovis and human mycobacterium tuberculosis and reagent kit thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010019822A1 (en) * 1997-06-25 2001-09-06 Kevin M. Gorman Multiplexed pcr assay for detecting disseminated mycobacterium avium complex infection
CN102286627A (en) * 2011-09-08 2011-12-21 北京利德曼生化股份有限公司 Simultaneous identification method for mycobacterium bovis and human mycobacterium tuberculosis and reagent kit thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEN ET AL: "Identification and Differentiation of Mycobacterium avium and M.intracellulare by PCR", 《JOURNAL OF CLINICAL MICROBIOLOGY》 *
SUPORN FOONGLADDA ET AL: "Multi-Probe Real-Time PCR Identification of Common Mycobacterium Species in Blood Culture Broth", 《JOURNAL OF MOLECULAR DIAGNOSTICS》 *
陈光 等: "基于DPO的四重荧光PCR检测常见分枝杆菌方法的建立与应用", 《中华检验医学杂志》 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107805666A (en) * 2016-09-07 2018-03-16 江苏奇天基因生物科技有限公司 A kind of method that mycobacterium avium-intracellulare complex is detected using isothermal amplification
CN108531622A (en) * 2017-03-06 2018-09-14 广州市宝创生物技术有限公司 The hybond membrane item and detection kit of mycobacterium tuberculosis complex and the compound group of the extracellular mycobacteria of bird-
CN108531622B (en) * 2017-03-06 2021-07-20 广州市宝创生物技术有限公司 Hybrid membrane strip and detection kit for mycobacterium tuberculosis complex and avian-intracellular mycobacterium tuberculosis complex
CN110938702A (en) * 2019-11-28 2020-03-31 北京市结核病胸部肿瘤研究所 Method for detecting mycobacterium avium by real-time fluorescent PCR and application thereof
CN110938702B (en) * 2019-11-28 2022-11-01 北京市结核病胸部肿瘤研究所 Method for detecting mycobacterium avium by real-time fluorescent PCR and application thereof
CN112538539A (en) * 2020-11-26 2021-03-23 中国医学科学院北京协和医院 Kit and system for detecting mycobacterium avium
CN112538541A (en) * 2020-11-26 2021-03-23 中国医学科学院北京协和医院 Kit and system for detecting M.intracellulare
CN112538539B (en) * 2020-11-26 2022-09-23 中国医学科学院北京协和医院 Kit and system for detecting mycobacterium avium
CN112538541B (en) * 2020-11-26 2022-10-14 中国医学科学院北京协和医院 Kit and system for detecting M.intracellulare

Similar Documents

Publication Publication Date Title
CN105219882A (en) Mycobacterium avium-intracellulare compound group detects by primer and probe and its detection method
Mirhendi et al. Colony PCR is a rapid and sensitive method for DNA amplification in yeasts
CN102102124B (en) Multiplex fluorescence PCR (Polymerase Chain Reaction) detection kit for typhoid/paratyphoid saimonella
CN1995380B (en) Method for detecting and identifying mycobacterium tuberculosis strain and its dedicated reagent kit
CN103468811B (en) Yersinia enterocolitica virulence gene multiplex-PCR (Polymerase Chain Reaction) detection primer group and kit
CN103421898B (en) The triple real-time fluorescent PCR testing primer of methicillin-resistant staphylococcus aureus, probe, detection kit and detection method
CN101023170A (en) Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith
Romeo et al. A multiplex PCR protocol for rapid identification of Candida glabrata and its phylogenetically related species Candida nivariensis and Candida bracarensis
CN105483214A (en) Mycobacterium tuberculosis detection kit and application thereof
CN102747144B (en) Triplex real-time fluorescence PCR detection primers, probes, detection kit and detection method for three bacterial
Castellanos et al. Single nucleotide polymorphisms in the IS 900 sequence of Mycobacterium avium subsp. paratuberculosis are strain type specific
CN103014135B (en) A kind of method identifying mycobacterium tuberculosis
CN104131100A (en) Fluorescent PCR reaction liquid and kit for mycobacterium parting identification
Zakham et al. Evaluation of conventional molecular diagnosis of Mycobacterium tuberculosis in clinical specimens from Morocco
CN103205485B (en) Method of detecting nucleotides of Bacillus cereus, primers for detecting and probes
CN102168131B (en) Primer for amplifying specific regions of common pathogenic type Legionella gyrB genes and application thereof
CN105256052B (en) A kind of kit and its detection method for Legionella quick detection and parting
CN105154538B (en) The primer and method of a kind of Legionella quick detection and parting
CN106916903A (en) The real-time fluorescence RT PCR detection methods and kit of mycobacterium tuberculosis 85B mRNA
CN102286627B (en) Simultaneous identification method for mycobacterium bovis and human mycobacterium tuberculosis and reagent kit thereof
Chimara et al. Molecular characterization of Mycobacterium kansasii isolates in the State of São Paulo between 1995-1998
CN107619879A (en) A kind of primer pair and its application for being used to identify Dendrobidium huoshanness and dendrobium candidum
CN107058522A (en) Kit and method for detecting mycobacterium tuberculosis and non-tuberculous mycobacteria
Ahlstrom et al. Relative frequency of 4 major strain types of Mycobacterium avium ssp. paratuberculosis in Canadian dairy herds using a novel single nucleotide polymorphism-based polymerase chain reaction
CN112553350A (en) Method for rapidly detecting multiple mycobacteria

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160106